Non-GAAP operating margin was 9.7%, compared with 15.5% in the first quarter of 2011. This decrease was primarily due to the reasons mentioned in the above discussion of GAAP operating margin.
Net income decreased 42.5% year over year to $1.7 million, primarily due to lower profit from operations and lower other income, including lower government subsidies. These items were partially offset by higher gains recognized on foreign exchange forward contracts.
Non-GAAP net income was $3.1 million, a decrease of 29.3% from $4.4 million in the first quarter of 2011. This was primarily due to the reasons mentioned in the above discussion of GAAP net income.
Diluted earnings per ADS were $0.09, which compares with $0.16 in the first quarter of 2011.
Non-GAAP diluted earnings per ADS were $0.17, which compares with $0.23 in the first quarter of 2011.
Financial Position As of March 31, 2012, the Company had cash and cash equivalents of $34.0 million and no debt outstanding. During the quarter, capital expenditures totaled $6.3 million, primarily from the investment in leasehold improvements of a new building dedicated to one of our major customers, the equipment acquired from Charles River, as well as payments related to the build-out of our Fengxian manufacturing facility.
Full Year 2012 GuidanceThe Company reconfirms its guidance for the full year 2012. The Company expects:
|SOURCE ShangPharma Corporation|
Copyright©2010 PR Newswire.
All rights reserved